Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Auriacombe

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Medical Research and Opinion|December 23, 2003
No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatmentS Auriacombe, J-J Pere,
Revue Neurologique|May 15, 2012
[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia]B Croisile, S Auriacombe, F Etcharry-Bouyx, et al.
Current Medical Research and Opinion|July 4, 2002
Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezilS Auriacombe, J J Pere, Y Loria-Kanza, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 8, 2009
A 15-year population-based cohort study of the incidence of Parkinson's disease and dementia with Lewy bodies in an elderly French cohortF Perez, C Helmer, J F Dartigues, et al.
Revue Neurologique|March 19, 2010
[Semantic and letter fluency tasks: normative data in an elderly population of 70 years old and over from the PAQUID cohort]N Raoux, M Le Goff, S Auriacombe, et al.
Neurology|April 1, 1995
Dementia in Parkinson's disease: a population-based study in ambulatory and institutionalized individualsF Tison, J F Dartigues, S Auriacombe, et al.
Neurology|April 23, 2010
Validity of the free and cued selective reminding test in predicting dementia: the 3C studyS Auriacombe, C Helmer, H Amieva, et al.
International Journal of Clinical Practice|January 18, 2006
Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatmentT Dantoine, S Auriacombe, M Sarazin, et al.
L'Encephale|April 29, 1998
[Adverse seizure reactions after electroconvulsive therapy. Study of personal cases and review of the literature]L Glénisson, M Auriacombe, T Fernandez, et al.
The Journal of Nutrition, Health & Aging|January 1, 2008
Early prevention at public health issueJ F Dartigues, C Helmer, K Peres, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Medical Research and Opinion|December 23, 2003
No donepezil discontinuation effect in patients with Alzheimer's disease who were switched to rivastigmine after failing to benefit from donepezil treatmentS Auriacombe, J-J Pere,
Revue Neurologique|May 15, 2012
[The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia]B Croisile, S Auriacombe, F Etcharry-Bouyx, et al.
Current Medical Research and Opinion|July 4, 2002
Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezilS Auriacombe, J J Pere, Y Loria-Kanza, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 8, 2009
A 15-year population-based cohort study of the incidence of Parkinson's disease and dementia with Lewy bodies in an elderly French cohortF Perez, C Helmer, J F Dartigues, et al.
Revue Neurologique|March 19, 2010
[Semantic and letter fluency tasks: normative data in an elderly population of 70 years old and over from the PAQUID cohort]N Raoux, M Le Goff, S Auriacombe, et al.
Neurology|April 1, 1995
Dementia in Parkinson's disease: a population-based study in ambulatory and institutionalized individualsF Tison, J F Dartigues, S Auriacombe, et al.
Neurology|April 23, 2010
Validity of the free and cued selective reminding test in predicting dementia: the 3C studyS Auriacombe, C Helmer, H Amieva, et al.
International Journal of Clinical Practice|January 18, 2006
Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatmentT Dantoine, S Auriacombe, M Sarazin, et al.
L'Encephale|April 29, 1998
[Adverse seizure reactions after electroconvulsive therapy. Study of personal cases and review of the literature]L Glénisson, M Auriacombe, T Fernandez, et al.
The Journal of Nutrition, Health & Aging|January 1, 2008
Early prevention at public health issueJ F Dartigues, C Helmer, K Peres, et al.
Pageof 2